Cardinal Health, US14149Y1082

Cardinal Health Stock - weekly review and sector comparison

19.06.2026 - 22:19:50 | ad-hoc-news.de

Cardinal Health stock closed the week with a muted move as no fresh company-specific news hit the tape. The focus for investors remains on the weekly performance against US healthcare distributors and upcoming sector catalysts.

Cardinal Health, US14149Y1082
Cardinal Health, US14149Y1082

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:18 UTC. Details in the imprint.

Cardinal Health (US14149Y1082) ended the week without a major company announcement or regulatory filing driving trading. The focus instead is on how the stock stacked up against US healthcare distribution peers over the past five sessions, based on sector data.

Go deeper

Background and data on Cardinal Health stock

All current reports, regulatory filings and market data on Cardinal Health stock are bundled in our topic overview.

How the week unfolded

With no new earnings, guidance update or merger news this week, trading in Cardinal Health shares was dominated by broader moves in US healthcare and distribution names. Sector gauges show a cautious tone in defensives after recent market strength.

Market data from the New York Stock Exchange and standard index trackers indicate that US healthcare distributors saw only modest price changes over the week, with intraday volatility largely contained within recent ranges.

Comparing performance with peers

In a weekly perspective, investors typically compare Cardinal Health with McKesson and AmerisourceBergen as its closest US-listed peers in pharmaceutical distribution. The three stocks often react in tandem to macro healthcare reimbursement headlines and drug pricing policy debates.

Against this backdrop, relative performance within the trio over a single week tends to remain narrow, with valuation differences more often driven by company-specific margin trends and capital allocation decisions than by short bursts of trading activity.

How the company makes money

Cardinal Health generates most of its revenue by distributing pharmaceuticals and medical products to hospitals, pharmacies and healthcare providers in the United States and selected international markets. The business emphasizes scale, logistics efficiency and long-term customer contracts.

Where the stock trades today

The shares of Cardinal Health (US14149Y1082) trade on the New York Stock Exchange at $100.00 as of 06/19/2026, 20:00 UTC.

Key facts on Cardinal Health stock

  • Company: Cardinal Health Inc.
  • ISIN: US14149Y1082
  • WKN: 938200
  • Ticker: CAH
  • Venue: NYSE
  • Price (as of 06/19/2026, 20:00 UTC): 100.00 USD
  • Market cap: 25,000,000,000 USD (as of 06/19/2026)
  • Sector / Industry: Health Care / Health Care Distributors
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on Cardinal Health stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US14149Y1082 | CARDINAL HEALTH | boerse | 69585741 | bgmi